In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice

scientific article published on 01 July 1989

In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID2499626

P50authorMichael T LotzeQ89121415
Steven RosenbergQ2347448
P2093author name stringRudikoff S
Nordan RP
Mulé JJ
Jablons DM
McIntosh JK
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)162-167
P577publication date1989-07-01
P1433published inJournal of ImmunologyQ3521441
P1476titleIn vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice
P478volume143

Reverse relations

cites work (P2860)
Q34247741Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages
Q36350671Antitumor activity of recombinant interleukin 6 in mice
Q36631630Changes in Mobility of the Golden Hamster with Induction of an IL-1-Induced Arthritis
Q42475817Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer
Q34132434Dietary lipids and calorie restriction affect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice
Q68499138Differential augmentation of in vivo natural killer cytotoxicity in normal primates with recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor
Q35602921Evidence for the involvement of interleukin 6 in experimental cancer cachexia
Q28533317Functional characterization of detergent-decellularized equine tendon extracellular matrix for tissue engineering applications
Q34288655IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation
Q71739906Interaction of interleukin-6, tumour necrosis factor and interleukin-1 during Listeria infection
Q41807421Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids
Q35602202Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia
Q39232767Interleukin-2 in cancer treatment: disappointing or (still) promising? A review
Q35993599Interleukin-6 serum level and monocyte production in head and neck cancer
Q74397599Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker
Q42082745Mesangial cell-matrix interactions. Effects on mesangial cell growth and cytokine secretion
Q35945218Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors
Q40754979Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity
Q37803895Rationale for immunotherapy of renal cell carcinoma
Q36231011Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor
Q36761832Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock
Q39830126The decrease in nonsplenic interleukin-6 (IL-6) production after splenectomy indicates the existence of a positive feedback loop of IL-6 production during endotoxemia in dogs.
Q72919717The effects of a biological response modifier, OK-432, on tumor-induced alterations in the host metabolism

Search more.